| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 04/23/2008 | EP1774033A4 Multiplexing assays for analyte detection |
| 04/23/2008 | CN101164542A Use of mometasone furoate for preparing drug |
| 04/15/2008 | CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 04/09/2008 | CN101157714A Hedera helix saponin, preparation method and antineoplastic use thereof |
| 04/09/2008 | CN101156860A Use of mometasone furoate for treating airway passage and lung diseases |
| 04/08/2008 | US7355056 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 04/03/2008 | WO2007076163A3 Biodiesel production processes and biodiesel produced therefrom |
| 04/02/2008 | EP1905444A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 04/02/2008 | CN100378119C Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/02/2008 | CN100378118C Pharmaceutical compositions having appetite suppressant activity |
| 03/26/2008 | CN100376595C Promoter for the production of hyaluronic acid containing ginsenoside compound K |
| 03/25/2008 | CA2295455C Process for the preparation of mometasone furoate |
| 03/13/2008 | WO2008028584A1 Preparations for oral administration (i) |
| 03/06/2008 | WO2008026300A1 Neem seed-derived therapeutic agent for malignant tumor |
| 03/06/2008 | WO2007089688A3 Na/k-atpase ligand |
| 02/28/2008 | WO2008022875A1 Process for preparing a composition comprising steroidal glycosides |
| 02/28/2008 | US20080051575 capable of switching between the two states in response to at least actinic radiation; thermally reversible |
| 02/28/2008 | CA2661593A1 Process for preparing a composition comprising steroidal glycosides |
| 02/27/2008 | CN101133075A Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptitde production |
| 02/21/2008 | US20080045704 Photochromic compounds |
| 02/21/2008 | US20080044500 extract of a plant of the family Liliaceae; Aloe vera; can be safely ingested without causing acute hypoglycemia and has a long-term blood glucose level control action to decrease the hemoglobin Alc level |
| 02/13/2008 | CN101121743A Process for extracting anticancer product from natural plant |
| 02/13/2008 | CN101121742A Panaxadiol fatty acid esters derivatives, preparation method and application thereof in pharmacy |
| 02/13/2008 | CN100368425C 6,7-oxygenated steroids and uses related thereto |
| 01/30/2008 | EP1882477A1 Drugs, food or drink for improving pancreatic functions |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/24/2008 | US20080020988 Brain cell- or nerve cell-protecting agents comprising medicinal ginseng |
| 01/16/2008 | CN101104633A Technique for preparing astragaloside by hydrolyzing astragaloside |
| 01/02/2008 | CN100358528C Use of mometasone furoate for treating airway passage and lung diseases |
| 12/26/2007 | EP1868613A2 Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine |
| 12/26/2007 | CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/20/2007 | US20070292967 Assay for Ligands of the Ecdysone Receptor |
| 12/12/2007 | CN101085802A Method for preparing Notoginsen triterpenes |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 11/08/2007 | WO2007070598A9 Nucleotide and oligonucleotide prodrugs |
| 11/06/2007 | CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 11/01/2007 | US20070254859 Compounds exhibiting efflux inhibitor activity and composition and uses thereof |
| 10/24/2007 | CN101060850A Drugs, food or drink for improving pancreatic functions |
| 10/17/2007 | CN100343271C C27-steroid antitumour medicine |
| 10/17/2007 | CN100343270C Process for extracting anticancer product from natural plant |
| 10/11/2007 | WO2007115187A2 Monetizing service calls through advertising |
| 10/11/2007 | WO2007112573A1 Nitrate esters of sterols/stanols and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| 10/10/2007 | EP1414843B1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 10/04/2007 | US20070232578 Crystalline forms of ciclesonide |
| 09/13/2007 | US20070213280 Steroidal Saponins Compound, the Process for Producing the Same and the Use Thereof |
| 09/12/2007 | CN101032535A Extracting purified ginsenoside from leaves of Panax quinquefolium and ginseng at the same time and the preparing method thereof |
| 09/11/2007 | CA2372720C Androgen glycosides and androgenic activity thereof |
| 09/05/2007 | CN101031580A Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 08/30/2007 | WO2007060206A3 Further crystalline forms of rostafuroxin |
| 08/23/2007 | WO2007094166A1 Therapeutic agent for spinal cord injury |
| 08/23/2007 | WO2006124012A3 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production |
| 08/14/2007 | CA2421302C 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/09/2007 | CA2641303A1 Na/k-atpase ligand |
| 07/26/2007 | US20070173476 Exposing double stranded polynucleotide comprised of a sense strand and an antisense strand to target nucleic acid and wherein at least one strand comprises at least one orthoester modified nucleotide; medical diagnosis; genetic engineering |
| 07/19/2007 | WO2007080951A1 Process for production of steroids |
| 07/19/2007 | WO2007016656A8 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 07/19/2007 | US20070167384 Modified polynucleotides for use in rna interference |
| 07/17/2007 | CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/11/2007 | CN1325509C Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/09/2007 | CA2635370A1 Modulators of hypoxia inducible factor-1 and related uses |
| 07/05/2007 | US20070154573 Method of preparing and using a cold extract from the leaves of nerium oleander |
| 07/05/2007 | CA2629121A1 Processes of producing biodiesel and biodiesel produced therefrom |
| 07/03/2007 | CA2133607C Corticoid -17,21-dicarboxylic esters and corticosteroid 17-caboxylic esters 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/03/2007 | CA2130943C Corticosteroid 17-alkyl carbonate 21-[o]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 06/28/2007 | US20070149462 Nucleotide and oligonucleotide prodrugs |
| 06/26/2007 | US7235655 Processes to prepare eplerenone |
| 06/26/2007 | US7235267 Brain cell or nerve cell-protecting agents comprising medicinal ginseng |
| 06/21/2007 | US20070142631 Enzyme inhibiton immunoassay |
| 06/21/2007 | US20070142307 Hormone replacement therapy; menopause therapy; sexual disorders, vasomotor symptoms, atrophic vaginitis, and osteoporosis. |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/14/2007 | US20070135358 Steroid modified solatrioses |
| 06/13/2007 | CN1978459A Compound Ananaside A, and its preparing method and anti-tumour use |
| 06/07/2007 | WO2007016656A3 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 06/07/2007 | WO2006113495A3 Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof |
| 05/31/2007 | WO2007060206A2 Further crystalline forms of rostafuroxin |
| 05/24/2007 | WO2005123959A3 Multiplexing assays for analyte detection |
| 05/18/2007 | WO2007056326A2 Compositions and methods for inhibiting expression of nav1.8 gene |
| 05/18/2007 | CA2626584A1 Compositions and methods for inhibiting expression of nav1.8 gene |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315864C Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17beta-carboxylic acid |
| 05/10/2007 | US20070106072 7a-Furyl or thienyl-substituted steroid compounds |
| 05/10/2007 | US20070105806 Administering to a patient in needs of treatment, prevention or management of neuropathic pain, a therapeutically or prophylactically effective amount of a double-stranded RNA (dsRNA), consists of a sense strand and an antisense strand that are complementary to each other |
| 05/03/2007 | US20070100140 used to prepare eplerenone; intermediates |
| 05/03/2007 | US20070099852 Cucurbitacin compounds |
| 05/02/2007 | EP1778715A2 Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 04/25/2007 | CN1951410A Protecting agent for brain cell or nerve cell, consisting of ginseng |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2073855C Glycoalkaloids for controlling cellular autophagy |
| 04/19/2007 | WO2007043305A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043302A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1775304A1 Process for production of steroids |
| 04/18/2007 | EP1774033A2 Multiplexing assays for analyte detection |
| 04/12/2007 | US20070082336 Methods for protein labeling based on acyl carrier protein |
| 03/29/2007 | WO2007034851A1 Visceral fat accumulation inhibitor |
| 03/28/2007 | CN1935830A Upright datura flower steroid-lactone component, and its preparation and pharmaceutical use for antitumour |
| 03/28/2007 | CN1935215A Datura flower total steroid, and its preparing method and use |
| 03/22/2007 | US20070066814 Steroid modified chacotrioses and solatrioses |